ROBERT ROY HENRY

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
    Robert R Henry
    VA San Diego Healthcare System, San Diego, CA and University of California, San Diego, La Jolla, CA Electronic address
    J Diabetes Complications 28:393-8. 2014
  2. doi New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)
    Robert R Henry
    Center for Metabolic Research, VA San Diego Healthcare System and University of California San Diego, San Diego, CA, USA Electronic address
    J Diabetes Complications 27:508-18. 2013
  3. pmc Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes
    Robert R Henry
    University of California, San Diego, La Jolla, California, USA
    Diabetes Care 36:2559-65. 2013
  4. doi Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial
    Robert R Henry
    University of California San Diego and Veteran Affairs San Diego Healthcare System, San Diego, California 92161, USA
    J Clin Endocrinol Metab 97:2370-9. 2012
  5. ncbi Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program
    Robert R Henry
    University of California San Diego School of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California 92161, USA
    Endocr Pract 17:906-13. 2011
  6. pmc Actos Now for the prevention of diabetes (ACT NOW) study
    Ralph A DeFronzo
    Texas Diabetes Institute and University of Texas Health Science Center, San Antonio, TX, USA
    BMC Endocr Disord 9:17. 2009
  7. ncbi Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects
    Robert R Henry
    VA San Diego Healthcare System, Section of Diabetes Endocrinology, San Diego, California 92161, USA
    Diabetes Care 26:764-9. 2003
  8. doi Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
    R R Henry
    Section of Diabetes, Endocrinology and Metabolism, VA San Diego Healthcare System and University of California San Diego, San Diego, CA 92161, USA
    Diabetes Obes Metab 14:40-6. 2012

Research Grants

Collaborators

Detail Information

Publications8

  1. doi Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
    Robert R Henry
    VA San Diego Healthcare System, San Diego, CA and University of California, San Diego, La Jolla, CA Electronic address
    J Diabetes Complications 28:393-8. 2014
    ..Evaluate the efficacy and tolerability of ITCA 650 in subjects with type 2 diabetes treated for up to 48 weeks...
  2. doi New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)
    Robert R Henry
    Center for Metabolic Research, VA San Diego Healthcare System and University of California San Diego, San Diego, CA, USA Electronic address
    J Diabetes Complications 27:508-18. 2013
    ....
  3. pmc Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes
    Robert R Henry
    University of California, San Diego, La Jolla, California, USA
    Diabetes Care 36:2559-65. 2013
    ..To evaluate ITCA 650, a continuous subcutaneous miniature osmotic pump delivery system of exenatide versus twice-daily exenatide injections (Ex-BID) in subjects with type 2 diabetes...
  4. doi Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial
    Robert R Henry
    University of California San Diego and Veteran Affairs San Diego Healthcare System, San Diego, California 92161, USA
    J Clin Endocrinol Metab 97:2370-9. 2012
    ..This study assessed the efficacy and safety of once-weekly taspoglutide in patients with type 2 diabetes mellitus inadequately controlled with metformin plus pioglitazone compared with placebo...
  5. ncbi Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program
    Robert R Henry
    University of California San Diego School of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California 92161, USA
    Endocr Pract 17:906-13. 2011
    ..To compare liraglutide versus common antihyperglycemic treatments in reducing hemoglobin A1c (A1C) values across multiple levels of baseline glycemic control and in reaching glycemic targets...
  6. pmc Actos Now for the prevention of diabetes (ACT NOW) study
    Ralph A DeFronzo
    Texas Diabetes Institute and University of Texas Health Science Center, San Antonio, TX, USA
    BMC Endocr Disord 9:17. 2009
    ..TRIAL REGISTRATION: clinical trials.gov identifier: NCT00220961...
  7. ncbi Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects
    Robert R Henry
    VA San Diego Healthcare System, Section of Diabetes Endocrinology, San Diego, California 92161, USA
    Diabetes Care 26:764-9. 2003
    ..This study examined the effects on pulmonary function, pharmacokinetics, and pharmacodynamics of inhaled insulin in asthmatic and nonasthmatic subjects without diabetes...
  8. doi Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
    R R Henry
    Section of Diabetes, Endocrinology and Metabolism, VA San Diego Healthcare System and University of California San Diego, San Diego, CA 92161, USA
    Diabetes Obes Metab 14:40-6. 2012
    ..Colesevelam lowers glucose and low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus. This study examined the mechanisms by which colesevelam might affect glucose control...

Research Grants4

  1. Role of Glycogen Synthase Kinase 3 In Type 2-Diabetes
    Robert Henry; Fiscal Year: 2004
    ..abstract_text> ..